|
|
|
|
|
|
|
|
1. |
Record Nr. |
UNINA9910467388903321 |
|
|
Autore |
Spohr Hans-Ludwig |
|
|
Titolo |
Fetal alcohol syndrome : a lifelong challenge / / Hans-Ludwig Spohr ; in collaboration with Heike Wolter ; translated by Betteke Maria van Noort, Heike Wolter and Hans-Ludwig Spohr |
|
|
|
|
|
|
|
Pubbl/distr/stampa |
|
|
Berlin ; ; Boston : , : De Gruyter, , [2018] |
|
©2018 |
|
|
|
|
|
|
|
|
|
ISBN |
|
3-11-043387-7 |
3-11-043656-6 |
|
|
|
|
|
|
|
|
Descrizione fisica |
|
1 online resource (308 pages) : illustrations (some color) |
|
|
|
|
|
|
Disciplina |
|
|
|
|
|
|
Soggetti |
|
Fetal alcohol spectrum disorders |
Electronic books. |
|
|
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
Nota di bibliografia |
|
Includes bibliographical references and index. |
|
|
|
|
|
|
Nota di contenuto |
|
The syndrome -- Diagnosis of fetal alcohol syndrome -- The 4-digit diagnostic code -- Neuropsychological aspects of fetal alcohol syndrome -- Diagnostic characteristics across lifespan -- Comorbid disorders and differential diagnosis of FAS -- Epidemiology -- Teratogenic effects of alcohol -- Effects of prenatal exposure to nicotine or illegal substances -- Biomarker for the detection of maternal alcohol use during pregnancy -- Neuropathological aspects and pathogenesis of FASD -- Genetic and epigenetic aspects of fetal alcohol syndrome -- Fetal alcohol syndrome in adults -- Diagnosing fetal alcohol syndrome in adulthood -- Treatment and intervention programs -- Prevention of FAS and FASD -- Awareness and support in other European countries : governmental policy and social law. |
|
|
|
|
|
|
|
|
Sommario/riassunto |
|
"This book presents a detailed description of fetal alcohol syndrome as well as fetal alcohol spectrum disorders with respect to their clinical presentation, diagnosis, epidemiology, and pathogenesis. It also includes detailed considerations of underlying psychopathology, prevention, and therapy as well as the social consequences and impacts to patients"--Provided by publisher. |
|
|
|
|
|
|
|